Middenmeer, The Netherlands.
As per June 1st 2012 The University Medical Center in Leiden (LUMC) was the first to receive the Artemis Handheld System for clinical use. The LUMC already has a system for pre-clinical use.
Both systems are being used within the CTMM Musis program, a research effort that will bring near-infrared optical imaging into the clinic for image guided cancer surgery.
Quest Medical Imaging is participating in consortia with several other developers of tumor targeted probes. Another system has been send to the US and several other will follow on short notice
How the Artemis Handheld camera system works
Surgery is often the first step in cancer treatment because it can be used for both diagnosis and treatment. More than half of the people diagnosed with cancer will have some type of surgery at some point. The most effective way to treat the cancer is by removing the tumor tissue and additional sites of disease spread (lymph nodes) completely. Of course the clean tissue around these sites should be left intact. To meet both requirements, it is crucial that the surgeon has a clear sight of (the margins of) the tumor, lymph nodes, and adjacent critical structures, such as nerves and blood vessels. Currently the biomedical sector is developing new generation of fluorescent probes that can be injected and specifically stick to the cancerous tissue. During the surgery, guided by the Artemis Handheld camera system, these fluorescent probes will light up and display the tumors clearly. This may enable the surgeon to remove the tumor and other diseased tissue very precisely, potentially improving the quality of life and life expectancy of cancer patients.
About Quest Medical Imaging
Quest Medical Imaging is the Dutch innovator in the area of bio-photonic camera design for medical applications. The company designs and manufactures cutting-edge camera systems based on broad spectrum fluorescence imaging that are essential for a variety of open and minimally invasive surgical applications.